1887

Abstract

We are becoming increasingly reliant on the effectiveness of biocides to combat the spread of Gram-negative multi-drug-resistant (MDR) pathogens, including . It has been shown that chlorhexidine exposure can lead to mutations in the efflux pump repressor regulators SmvR and RamR, but the contribution of each individual efflux pump to biocide tolerance is unknown.

Multiple efflux pumps, including SmvA and AcrAB-TolC, are involved in increased tolerance to biocides. However, strains with upregulated AcrAB-TolC caused by biocide exposure are more problematic due to their increased MDR phenotype.

To investigate the role of AcrAB-TolC in the tolerance to several biocides, including chlorhexidine, and the potential threat of cross-resistance to antibiotics through increased expression of this efflux pump.

Antimicrobial susceptibility testing was performed on isolates with mutations selected for after exposure to chlorhexidine, as well as transposon mutants in components and regulators of AcrAB-TolC. RTPCR was used to detect the expression levels of this pump after biocide exposure. Strains from the globally important ST258 clade were compared for genetic differences in -TolC and its regulators and for phenotypic differences in antimicrobial susceptibility.

Cross-resistance to antimicrobials was observed following mutations in . Exposure to chlorhexidine led to increased expression of and its activator , and transposon mutants in AcrAB-TolC have increased susceptibility to several biocides, including chlorhexidine. Variations in within the ST258 clade led to an increase in tolerance to certain biocides, although this was strain dependent. One strain, MKP103, that had increased levels of biocide tolerance showed a unique mutation in that was reflected in enhanced expression of and . MKP103 transposon variants were able to further enhance their tolerance to specific biocides with mutations affecting SmvA.

Biocide tolerance in is dependent upon several components, with increased efflux through AcrAB-TolC being an important one.

Funding
This study was supported by the:
  • UKHSA (Award 111743)
    • Principle Award Recipient: MarkSutton
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001496
2022-03-24
2024-04-16
Loading full text...

Full text loading...

/deliver/fulltext/jmm/71/3/jmm001496.html?itemId=/content/journal/jmm/10.1099/jmm.0.001496&mimeType=html&fmt=ahah

References

  1. Poole K. Efflux pumps as antimicrobial resistance mechanisms. Ann Med 2007; 39:162–176 [View Article] [PubMed]
    [Google Scholar]
  2. Karatzas KAG, Webber MA, Jorgensen F, Woodward MJ, Piddock LJV et al. Prolonged treatment of Salmonella enterica serovar Typhimurium with commercial disinfectants selects for multiple antibiotic resistance, increased efflux and reduced invasiveness. J Antimicrob Chemother 2007; 60:947–955 [View Article] [PubMed]
    [Google Scholar]
  3. Sanchez P, Moreno E, Martinez JL. The biocide triclosan selects Stenotrophomonas maltophilia mutants that overproduce the SmeDEF multidrug efflux pump. Antimicrob Agents Chemother 2005; 49:781–782 [View Article] [PubMed]
    [Google Scholar]
  4. Colclough AL, Alav I, Whittle EE, Pugh HL, Darby EM et al. RND efflux pumps in Gram-negative bacteria; regulation, structure and role in antibiotic resistance. Future Microbiol 2020; 15:143–157 [View Article] [PubMed]
    [Google Scholar]
  5. Masuda N, Sakagawa E, Ohya S, Gotoh N, Tsujimoto H et al. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2000; 44:3322–3327 [View Article] [PubMed]
    [Google Scholar]
  6. Ruzin A, Keeney D, Bradford PA. AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex. J Antimicrob Chemother 2007; 59:1001–1004 [View Article] [PubMed]
    [Google Scholar]
  7. Du D, Wang Z, James NR, Voss JE, Klimont E et al. Structure of the AcrAB-TolC multidrug efflux pump. Nature 2014; 509:512–515 [View Article] [PubMed]
    [Google Scholar]
  8. Weston N, Sharma P, Ricci V, Piddock LJV. Regulation of the AcrAB-TolC efflux pump in Enterobacteriaceae. Res Microbiol 2018; 169:425–431 [View Article] [PubMed]
    [Google Scholar]
  9. Okusu H, Ma D, Nikaido H. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J Bacteriol 1996; 178:306–308 [View Article] [PubMed]
    [Google Scholar]
  10. Moken MC, McMurry LM, Levy SB. Selection of multiple-antibiotic-resistant (mar) mutants of Escherichia coli by using the disinfectant pine oil: roles of the mar and acrAB loci. Antimicrob Agents Chemother 1997; 41:2770–2772 [View Article] [PubMed]
    [Google Scholar]
  11. McMurry LM, Oethinger M, Levy SB. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol Lett 1998; 166:305–309 [View Article] [PubMed]
    [Google Scholar]
  12. Ricci V, Piddock LJV. Only for substrate antibiotics are a functional AcrAB-TolC efflux pump and RamA required to select multidrug-resistant Salmonella Typhimurium. J Antimicrob Chemother 2009; 64:654–657 [View Article] [PubMed]
    [Google Scholar]
  13. Roe CC, Vazquez AJ, Esposito EP, Zarrilli R, Sahl JW. Diversity, virulence, and antimicrobial resistance in isolates from the newly emerging Klebsiella pneumoniae ST101 lineage. Front Microbiol 2019; 10:542 [View Article] [PubMed]
    [Google Scholar]
  14. Chen L, Mathema B, Pitout JDD, DeLeo FR, Kreiswirth BN. Epidemic Klebsiella pneumoniae ST258 is a hybrid strain. mBio 2014; 5:e01355–14 [View Article] [PubMed]
    [Google Scholar]
  15. Giske CG, Fröding I, Hasan CM, Turlej-Rogacka A, Toleman M et al. Diverse sequence types of Klebsiella pneumoniae contribute to the dissemination of blaNDM-1 in India, Sweden, and the United Kingdom. Antimicrob Agents Chemother 2012; 56:2735–2738 [View Article] [PubMed]
    [Google Scholar]
  16. Slipski CJ, Zhanel GG, Bay DC. Biocide selective TolC-independent efflux pumps in enterobacteriaceae. J Membr Biol 2018; 251:15–33 [View Article] [PubMed]
    [Google Scholar]
  17. Wand ME, Bock LJ, Bonney LC, Sutton JM. Mechanisms of increased resistance to chlorhexidine and cross-resistance to colistin following exposure of Klebsiella pneumoniae clinical isolates to chlorhexidine. Antimicrob Agents Chemother 2017; 61:e01162-16 [View Article] [PubMed]
    [Google Scholar]
  18. Wand ME, Jamshidi S, Bock LJ, Rahman KM, Sutton JM. SmvA is an important efflux pump for cationic biocides in Klebsiella pneumoniae and other Enterobacteriaceae. Sci Rep 2019; 9:1344 [View Article] [PubMed]
    [Google Scholar]
  19. Fang CT, Chen HC, Chuang YP, Chang SC, Wang JT. Cloning of a cation efflux pump gene associated with chlorhexidine resistance in Klebsiella pneumoniae. Antimicrob Agents Chemother 2002; 46:2024–2028 [View Article] [PubMed]
    [Google Scholar]
  20. Wand ME, Baker KS, Benthall G, McGregor H, McCowen JWI et al. Characterization of pre-antibiotic era Klebsiella pneumoniae isolates with respect to antibiotic/disinfectant susceptibility and virulence in Galleria mellonella. Antimicrob Agents Chemother 2015; 59:3966–3972 [View Article] [PubMed]
    [Google Scholar]
  21. Srinivasan VB, Singh BB, Priyadarshi N, Chauhan NK, Rajamohan G. Role of novel multidrug efflux pump involved in drug resistance in Klebsiella pneumoniae. PLoS One 2014; 9:e96288 [View Article] [PubMed]
    [Google Scholar]
  22. Bialek-Davenet S, Leflon-Guibout V, Tran Minh O, Marcon E, Moreau R et al. Complete deletion of the ramR gene in an in vitro-selected mutant of Klebsiella pneumoniae overexpressing the AcrAB efflux pump. Antimicrob Agents Chemother 2013; 57:672–673 [View Article] [PubMed]
    [Google Scholar]
  23. Hentschke M, Wolters M, Sobottka I, Rohde H, Aepfelbacher M. ramR mutations in clinical isolates of Klebsiella pneumoniae with reduced susceptibility to tigecycline. Antimicrob Agents Chemother 2010; 54:2720–2723 [View Article] [PubMed]
    [Google Scholar]
  24. Schneiders T, Amyes SGB, Levy SB. Role of AcrR and ramA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore. Antimicrob Agents Chemother 2003; 47:2831–2837 [View Article] [PubMed]
    [Google Scholar]
  25. Curiao T, Marchi E, Viti C, Oggioni MR, Baquero F et al. Polymorphic variation in susceptibility and metabolism of triclosan-resistant mutants of Escherichia coli and Klebsiella pneumoniae clinical strains obtained after exposure to biocides and antibiotics. Antimicrob Agents Chemother 2015; 59:3413–3423 [View Article] [PubMed]
    [Google Scholar]
  26. Webber MA, Whitehead RN, Mount M, Loman NJ, Pallen MJ et al. Parallel evolutionary pathways to antibiotic resistance selected by biocide exposure. J Antimicrob Chemother 2015; 70:2241–2248 [View Article] [PubMed]
    [Google Scholar]
  27. Ramage B, Erolin R, Held K, Gasper J, Weiss E et al. Comprehensive arrayed transposon mutant library of Klebsiella pneumoniae outbreak strain KPNIH1. J Bacteriol 2017; 199:20 [View Article] [PubMed]
    [Google Scholar]
  28. Blair JMA, Piddock LJV. How to measure export via bacterial multidrug resistance efflux pumps. mBio 2016; 7:e00840-16 [View Article] [PubMed]
    [Google Scholar]
  29. Afgan E, Baker D, Batut B, van den Beek M, Bouvier D et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res 2018; 46:W537–W544 [View Article] [PubMed]
    [Google Scholar]
  30. Hind CK, Dowson CG, Sutton JM, Jackson T, Clifford M et al. Evaluation of a library of FDA-approved drugs for their ability to potentiate antibiotics against multidrug-resistant gram-negative pathogens. Antimicrob Agents Chemother 2019; 63:e00769-19 [View Article] [PubMed]
    [Google Scholar]
  31. Langevin AM, Dunlop MJ. Stress introduction rate alters the benefit of AcrAB-TolC efflux pumps. J Bacteriol 2018; 200:e00525-17 [View Article] [PubMed]
    [Google Scholar]
  32. Lawler AJ, Ricci V, Busby SJW, Piddock LJV. Genetic inactivation of acrAB or inhibition of efflux induces expression of ramA. J Antimicrob Chemother 2013; 68:1551–1557 [View Article] [PubMed]
    [Google Scholar]
  33. Bailey AM, Paulsen IT, Piddock LJV. RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine. Antimicrob Agents Chemother 2008; 52:3604–3611 [View Article] [PubMed]
    [Google Scholar]
  34. Fàbrega A, Ballesté-Delpierre C, Vila J. Differential impact of ramRA mutations on both ramA transcription and decreased antimicrobial susceptibility in Salmonella Typhimurium. J Antimicrob Chemother 2016; 71:617–624 [View Article] [PubMed]
    [Google Scholar]
  35. Grimsey EM, Weston N, Ricci V, Stone JW, Piddock LJV. Overexpression of RamA, which regulates production of the multidrug resistance efflux pump AcrAB-TolC, increases mutation rate and influences drug resistance phenotype. Antimicrob Agents Chemother 2020; 64:e02460-19 [View Article] [PubMed]
    [Google Scholar]
  36. Lim SP, Nikaido H. Kinetic parameters of efflux of penicillins by the multidrug efflux transporter AcrAB-TolC of Escherichia coli. Antimicrob Agents Chemother 2010; 54:1800–1806 [View Article] [PubMed]
    [Google Scholar]
  37. Nikaido H, Pagès J-M. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev 2012; 36:340–363 [View Article]
    [Google Scholar]
  38. Kinana AD, Vargiu AV, May T, Nikaido H. Aminoacyl β-naphthylamides as substrates and modulators of AcrB multidrug efflux pump. Proc Natl Acad Sci USA 2016; 113:1405–1410 [View Article] [PubMed]
    [Google Scholar]
  39. Strahl H, Hamoen LW. Membrane potential is important for bacterial cell division. Proc Natl Acad Sci U S A 2010; 107:12281–12286 [View Article] [PubMed]
    [Google Scholar]
  40. Opperman TJ, Nguyen ST. Recent advances toward a molecular mechanism of efflux pump inhibition. Front Microbiol 2015; 6:421 [View Article]
    [Google Scholar]
  41. Jamshidi S, Sutton JM, Rahman KM. Mapping the dynamic functions and structural features of AcrB efflux pump transporter using accelerated molecular dynamics simulations. Sci Rep 2018; 8:10470 [View Article] [PubMed]
    [Google Scholar]
  42. Osei Sekyere J, Amoako DG. Carbonyl Cyanide m-Chlorophenylhydrazine (CCCP) reverses resistance to colistin, but not to carbapenems and tigecycline in multidrug-resistant enterobacteriaceae. Front Microbiol 2017; 8:228 [View Article] [PubMed]
    [Google Scholar]
  43. Saw HTH, Webber MA, Mushtaq S, Woodford N, Piddock LJV. Inactivation or inhibition of AcrAB-TolC increases resistance of carbapenemase-producing Enterobacteriaceae to carbapenems. J Antimicrob Chemother 2016; 71:1510–1519 [View Article] [PubMed]
    [Google Scholar]
  44. Sheng Z-K, Hu F, Wang W, Guo Q, Chen Z et al. Mechanisms of tigecycline resistance among Klebsiella pneumoniae clinical isolates. Antimicrob Agents Chemother 2014; 58:6982–6985 [View Article] [PubMed]
    [Google Scholar]
  45. Griffith JM, Basting PJ, Bischof KM, Wrona EP, Kunka KS et al. Experimental evolution of Escherichia coli K-12 in the Presence of Proton Motive Force (PMF) uncoupler carbonyl cyanide m-chlorophenylhydrazone selects for mutations affecting PMF-driven drug efflux pumps. Appl Environ Microbiol 2019; 85:e02792-18 [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001496
Loading
/content/journal/jmm/10.1099/jmm.0.001496
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error